Strattec (STRT) Insider Grant: CFO Receives Time‑Vesting and EBITDA‑Tied PRSUs
Rhea-AI Filing Summary
Strattec Security Corp (STRT) reporting person Matthew Pauli, SVP & CFO, was granted equity awards on 08/22/2025. He received 3,516 shares of restricted common stock that vest one-third on each anniversary of the grant (08/22/2026, 08/22/2027 and 08/22/2028). He also received 3,516 performance restricted stock units (PRSUs) that are contingent rights to receive common shares based on the issuer's EBITDA percentage over a three-year performance period ending 07/02/2028. Following the reported transactions, Mr. Pauli directly beneficially owns 8,707 shares of common stock. The Form 4 was signed via power of attorney on 08/26/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Executive received time‑based and performance‑based equity, aligning compensation with multi‑year EBITDA targets.
The filing discloses a standard mix of restricted stock and performance restricted stock units granted to the company's SVP & CFO. The restricted shares vest pro rata over three years, providing time‑based retention incentives; the PRSUs are tied to EBITDA percentage over a three‑year performance period ending July 2, 2028, creating a link between pay and company operating performance. The total award size (3,516 shares of each award type) and resulting direct ownership of 8,707 shares are modest in absolute terms and likely intended for retention and performance alignment rather than a material change in ownership. This disclosure is routine and conforms to typical insider grant reporting requirements.
TL;DR: Mix of time‑vesting and performance awards suggests standard executive pay practices focused on retention and EBITDA performance.
The transaction shows 3,516 restricted shares and 3,516 PRSUs granted on 08/22/2025. Time‑vesting (one‑third annually) supports retention through 2028, while PRSUs linked to EBITDA percentage over a defined three‑year period create a measurable performance hurdle. The awards carry a $0 reported price (standard for grants) and are reported as direct ownership. Given the reported post‑transaction holding of 8,707 shares, the grant is unlikely to be dilutive or materially change governance control, but it is material to executive compensation disclosures and investor transparency.